+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cementless Total Knee Arthroplasty Market Report and Forecast 2023-2031

  • PDF Icon


  • 160 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5805744
The global cementless total knee arthroplasty market value was USD 5 billion in 2022, driven by the increasing prevalence of knee osteoarthritis and the rising demand for more durable and long-lasting knee replacement solutions across the globe. The market size is anticipated to grow at a CAGR of 14.6% during the forecast period of 2023-2031 to achieve a value of USD 16.4 billion by 2031.

Cementless Total Knee Arthroplasty: Introduction

Cementless Total Knee Arthroplasty (TKA) is a surgical procedure used to replace a damaged or diseased knee joint with an artificial joint, also known as a prosthesis. Unlike cemented TKA, which relies on a cement-like substance to hold the components in place, cementless TKA uses a porous coating on the implant surfaces to allow bone ingrowth, promoting long-term stability and fixation.

Key Trends in the Cementless Total Knee Arthroplasty Market

Some key trends in the cementless total knee arthroplasty market are:
  • Advancements in Implant Design: The field of cementless TKA is witnessing continuous advancements in implant design. Manufacturers are focusing on developing implants with improved fixation and stability, enhanced wear resistance, and better range of motion. These advancements aim to provide long-lasting and durable solutions for patients undergoing total knee replacement
  • Materials and Surface Technologies: There is a growing emphasis on the development of advanced materials and surface technologies in cementless TKA. Innovations such as the use of titanium alloys and specialized coatings, such as hydroxyapatite, promote osseointegration and improve the longevity of the implant. These advancements enhance implant performance, reduce the risk of implant loosening, and contribute to better patient outcomes
  • Minimally Invasive Techniques: Minimally invasive surgical techniques have gained popularity in TKA procedures, including cementless TKA. These techniques involve smaller incisions, reduced soft tissue disruption, and faster recovery times compared to traditional open surgeries. Minimally invasive approaches minimize postoperative pain, reduce scarring, and provide improved functional outcomes for patients
  • Personalized and Patient-Specific Implants: The trend of personalized medicine has also extended to cementless TKA. The use of patient-specific implants and instrumentation, based on preoperative imaging and computer-assisted planning, allows for a more customized and precise fit. These patient-specific approaches aim to improve implant alignment, stability, and overall patient satisfaction
  • Navigation and Robotics: The integration of navigation systems and robotic-assisted technology in cementless TKA is becoming more prevalent. These technologies aid surgeons in achieving optimal implant positioning, alignment, and balance, leading to improved outcomes and reducing the risk of postoperative complications. Navigation and robotics provide real-time feedback and enhance surgical accuracy during the procedure

Cementless Total Knee Arthroplasty Market Segmentations

Market Breakup by Components

  • Tibial Component
  • Femoral Component

Market Breakup by End User

  • Hospitals
  • Orthopedic Centers
  • Other end-Users

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Cementless Total Knee Arthroplasty Market Scenario

The market for cementless Total Knee Arthroplasty (TKA) is experiencing significant growth due to the increasing prevalence of knee osteoarthritis and the rising demand for more durable and long-lasting knee replacement solutions. Cementless TKA offers several advantages over traditional cemented TKA, including improved implant longevity, enhanced bone preservation, and potential for better long-term clinical outcomes.

One of the key factors driving the market is the growing aging population worldwide, as older individuals are more prone to developing knee-related conditions. Moreover, advancements in implant design and materials, such as the use of titanium alloys and specialized coatings, have contributed to improved implant fixation and reduced the risk of implant loosening. These innovations have resulted in better patient satisfaction and long-term survivorship.

The market is also witnessing a shift towards personalized medicine, with the development of patient-specific implants and instrumentation. These advancements allow for a more customized fit and precise alignment, leading to improved implant stability and better patient outcomes. Additionally, the integration of navigation systems and robotic-assisted technology in cementless TKA surgeries has gained traction, as these tools assist surgeons in achieving optimal implant positioning and alignment.

Cementless Total Knee Arthroplasty Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Stryker
  • Smith & Nephew
  • Zimmer Biomet
  • Johnson & Johnson (DePuy Synthes)
  • B. Braun SE
  • Olympus Corporation (GROUP FH ORTHO)
  • DJO, LLC (Enovis)
  • Corin Group plc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cementless Total Knee Arthroplasty Market Overview
3.1 Cementless Total Knee Arthroplasty Market Historical Value (2016-2022)
3.2 Cementless Total Knee Arthroplasty Market Forecast Value (2023-2031)
4 Cementless Total Knee Arthroplasty Market Landscape
4.1 Cementless Total Knee Arthroplasty: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Cementless Total Knee Arthroplasty: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Cementless Total Knee Arthroplasty Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Cementless Total Knee Arthroplasty Market Segmentation
6.1 Cementless Total Knee Arthroplasty Market by Components
6.1.1 Market Overview
6.1.2 Tibial Component
6.1.3 Femoral Component
6.2 Cementless Total Knee Arthroplasty Market by End Users
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Orthopedic Centers
6.2.4 Other end-Users
6.3 Cementless Total Knee Arthroplasty Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Cementless Total Knee Arthroplasty
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cementless Total Knee Arthroplasty
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cementless Total Knee Arthroplasty
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Cementless Total Knee Arthroplasty
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cementless Total Knee Arthroplasty
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Stryker
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Smith & Nephew
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Zimmer Biomet
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Johnson & Johnson (DePuy Synthes)
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 B. Braun SE
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Olympus Corporation (GROUP FH ORTHO)
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 DJO, LLC (Enovis)
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Corin Group plc
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
19 Cementless Total Knee Arthroplasty - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket

Companies Mentioned

  • Stryker
  • Smith & Nephew
  • Zimmer Biomet
  • Johnson & Johnson (DePuy Synthes)
  • B. Braun SE
  • Olympus Corporation (GROUP FH ORTHO)
  • DJO LLC (Enovis)
  • Corin Group plc



Table Information